Background: Curcuma longa has biological effects. Its cardiovascular activities are yet to be scientifically studied.Objectives: To investigate the vasorelaxant effects of the aqueous extract of Curcuma longa (AECL).Methods: Aortic annuli of normotensive rats, with or without endothelium, were set up in a data storage system with nutrient solution in recipients, with scientifically recommended temperature, aeration and tension. Over contraction by Phenylephrine, the AECL (1, 3, 10, 30, 100, 300 and 1000 μg/mL) was incubated before and after incubation with atropine or L-name or indomethacin. An AECL concentration-response curve was also built over contractions caused by elevation of extracellular K + . Data were significant when p < 0.05, with GraphPad Prism 6.0 software resolutions.
Results:The AECL induced 100% vasorelaxation also in the endothelium-free annuli. The part of the endotheliumdependent effect had EC 50 = 4.32 ± 0.05 μg/mL. With inhibition of NO production, the EC 50 increased to 126.50 ± 2.35 μg/mL; after inhibition of prostacyclin production, to 124.6 ± 0.05 μg/mL; and after muscarinic blockade, to 437.10 ± 0.2 μg/mL. Opening of K + channels (relaxation of 56.98%) and VOCC blockade (relaxation of 31.56%) were evident.
Conclusion:AECL induced significant vasorelaxation, being more significant in the presence of endothelium. The muscarinic pathway seems to be the main one involved in this effect, followed by the NO production and prostacyclin pathways. The activity in K + channels by AECL was more significant than its VOCC blockade. The use of other models and tools to study action mechanisms will be important and elucidating.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.